4709 Golf Rd., Suite 803, Skokie, IL 60076
This tutorial is a
solid 8:45 a.m. to 4:30 p.m. day and covers the topics listed
below.
After this tutorial, youll have a solid grasp of what
patient-level
data is, of the nuances among different strands of patient level
data
and the bearing on the analyses performed. Youll have a good
appreciation of the offering of the major data vendors and
whats
brewing in the industry. Youll have the lowdown on fundamental
analyses
such as compliance and persistency (adherence), switching,
dosing, and
the like. You will also be exposed to dramatically novel
applications of
patient-level data (e.g.. spillover, influencers, molecular
targeting,
etc.). Last but not least, youll be better equipped back in the
ranch
to advise your company as to the best patient data course to
embark on,
to vet and select patient-level databases, to build the case for
patient-level data to upper management, and to enthuse analysts
already
overwhelmed with too much data.
MORNING
Jean-Patrick Tsang, PhD & MBA (INSEAD)
Jean-Patrick Tsang is the
Founder and President of Bayser, a Chicago-based consulting firm
dedicated to pharmaceuticals sales and marketing.
JP started up Bayser in April 1996 after a two-year stint in a larger
consulting firm. JP's contribution to the industry includes: adaptive
targeting based on individual promotion response curves, Hood Robin
principle for portfolio optimization, a probabilistic approach to the
managed care masking problem, a quota reallocation scheme to re-level
the managed care playing field, a four-point evaluation scheme to assess
co-promotion opportunities, a music-like notation to capture the terms
of a deal, and a CRM tool to enhance communication and planning between
the district manager and the sales rep.
JP is a big proponent of patient-level data, not only for the
longitudinal analyses, but also for loftier endeavors it supports such
as measuring hospital-retail spillover, identifying influencers &
spheres of influence, and opening up new targeting paradigms such as
system targeting.
JP publishes in Pharmaceutical Executive, Product Management Today,
and other trade magazines, and talks at PMSA, PMRG, CBI, SRI, and
IIRUSA. In a previous life, JP worked on the automation of the
design process of payloads for satellites, methaners/ethaners,
and cruise-liners. JP earned a Ph.D. in Artificial Intelligence
from Grenoble University and an MBA from
INSEAD in France. He can be reached at (847) 920-1000 or
bayser@bayser.com.
Igor Rudychev, PhD
Igor Rudychev is currently a Vice President with
Bayser. He has intimate working knowledge of patient-level and
patient-centric data, having completed several client engagements
involving identification of influencers and influence networks,
KOL's and referral patterns, mapping of institutional neighborhoods,
measurement of patient compliance and persistence, sources of business,
patient segmentation hospital-retail spillover, hospital/retail
switching, and the like.
In his patient-level data analyses, Igor leverages techniques from
advanced mathematics, statistics, artificial intelligence, and
elementary particle physics. In addition to performing and supervising
client projects, Igor is involved in fundamental research
pertaining to the deployment of
patient-level data to solve key business questions of the pharmaceutical
industry.
Igor co-authored articles with JP titled Distilling Influence
Networks and Referral Patterns using Patient-Level Data, Product
Management Today (April 2003 issue), "Taking Compliance and Persistence
Out of the Box", Journal of Longitudinal Data, Jan/Feb 2005 and
Compliance and Persistence: Emerging Issues with Imatinib Therapy,
British Journal of Nursing, upcoming.
Prior to joining Bayser, Igor conducted research in optimization
techniques applied to super string theory, the most promising avenue to
the unification of quantum mechanics and Einstein's theory of gravity.
Igor has a PhD in Theoretical Physics from Texas A&M. His hobbies
include guitar and chess (Russian Candidate Chess Master at 13). He can
be reached at (847) 679-8278 or igor@bayser.com.
Patient-Level Data Workshop in Chicago
Date: Thursday, April 22, 2010.
Venue: The Deer Path Inn, 255 East Illinois Road,
Lake Forest, IL 60045
Phone: (847) 234-2280
Reservation: Call Igor at (847) 679-8278 to reserve a seat now
Testimonials
This is what the attendees of the previous sessions are saying:
Sign up!
Should be required for anyone using this type of data!
JPs insights into where the industry is heading, the motivation of the data vendors and the pitfalls of using that data are most interesting. Very helpful!
Excellent review of various vendor capabilities and approach to working with vendors for quality, substance, content.
Review of concepts and appendix thorough!
Provides a complete understanding of the key differences in what elements are included in which sources.
Very good! Should be required for market research department.
Great job! This course applies to all levels of understanding/ knowledge
JPs humor most welcome! Great overview and explanation of what various databases contain.
JP and Igor were so knowledgeable about specific vendors offerings!
Intellectually challenging!
Excellent class notes plentiful and useful
Companies that attended
Pharmaceutical companies that attended our tutorials include: Abbott, AstraZeneca, Aventis, Bayer, Bayer Diagnostics, BMS, Boehringer-Ingelheim, Centocor/J&J, Eisai, Eli Lilly, Forest Labs, GSK, Janssen/J&J, Merck, Novartis, Novo Nordisk, Ortho Biotech/J&J, Pfizer, P&G, Takeda, Roche, Roche Diagnostics, Sanofi-Aventis, Solvay, Wyeth, and Yamanouchi.
Why Bayser
First off, you'll have an objective evaluation account of the patient industry. We have no vested interest in any patient-level data vendor and will give you the untainted truth straight from the gut. We'll tell you what data vendors are loath to admit.
Second, we have done considerable research and have solid client experience under the belt. Here is a list of recent articles we penned on patient-level data:
- Patient-level data come of age that appeared in the May 2003 issue of Pharmaceutical Executive and was reproduced in the Nov 2003 issue of the International Pharmaceutical Review.
- Distilling Influence Networks and Referral Patterns using Patient-Level Data in the April 2003 issue of Product Management Today
- Hospital to Home: The Rx Spillover effect, Pharmaceutical Executive, July 2003.
- Patient-Level Data: A New Level of Analysis, Pharmaceutical Marketing News, Aug 2003.
- Molecular Targeting, Medical Marketing Media, February 2004.
- Taking compliance and persistence out of the box, Journal of Longitudinal Data, Jan/Feb 2005, pp 78-85.
- Compliance and Persistence: Emerging Issues with Imatinib Therapy, British Journal of Nursing, upcoming.
- "Patient-centered sample optimization", work in progress.
Below conferences we chaired on patient-level data:
- Patient-Level Data Leverage emerging data to maximize market potential, Organizer and chairman of conference with CBI, Philadelphia, PA, June 5-6 2003.
- Anonymous Patient-Level Data Leverage emerging data to maximize market potential, Organizer and Chairman of conference with CBI, Philadelphia, PA, Nov 16-17 2003.
- Optimizing the use of patient-level data to enhance your marketing capabilities, chairman and leader of pre-conference workshop Introduction to classical and advanced patient-level analyses, PEA Conference, Park Hyatt, Philadelphia, PA, March 22-23, 2004.
- Upcoming: Patient-Level Data and Medicare Part D, co-chair, IIRUSA, Baltimore, Nov 2-3, 2005.
Below is a selection of conferences where we uncovered some insights regarding patient-level data:
- Measuring Hospital-Retail Spillover: Bridging and Holistic Techniques, PMSA 2003, Orlando, FL, May 4-7, 2003.
- Patient-Level Data Leverage emerging data to maximize market potential, Organizer and chairman of conference with CBI, Philadelphia, PA, June 5-6, 2003.
- Identification of Influencers using patient-level data, PMRG Fall 2003, San Diego, Sep 21-23, 2003.
- Nail down true ROI, PMC 2003 Washington DC, Oct 2003 (co-presentation with Sanofi).
- Anonymous Patient-Level Data Leverage emerging data to maximize market potential, Organizer and Chairman of conference with CBI, Philadelphia, PA, Nov 16-17 2003.
- Building sociograms of physicians using upstream targeting, IIRUSA conference on Using market research to advance innovation and new product development for pharmaceuticals: Aligning marketing and development for commercial success, Sheraton Rittenhouse Square Hotel, Philadelphia, PA, Feb 24-26, 2004 (co-presentation with Sepracor).
- Optimizing the use of patient-level data to enhance your marketing capabilities, chairman and leader of pre-conference workshop Introduction to classical and advanced patient-level analyses, PEA Conference, Park Hyatt, Philadelphia, PA, March 22-23, 2004.
- How to harness the power of patient-level data, workshop leader, Med Ad News Conference on Pharmaceutical Marketing Partnerships, New York, NY, April 19-21, 2004.
- Challenges and opportunities involved in deploying patient-level data in pharmaceutical companies Panel Moderator, CBI 2nd annual conference on patient-level data, Philadelphia, PA, June 3-4 2004.
- Identifying KOL's for MSL's, PEA conference on Best Practices for Medical Science Liaisons, Allertown Crown Plaza, Chicago, June 25, 2004.
- Transcending Compliance and Persistency using Patient-Level Data, Fall 2004 PMRG, Westin Copley Place, Boston, Sep 19-21, 2004.
- Patient-Level Data: Overview and Analysis, PBIRG Education Series, Olde Mill Inn at Basking Ridge, New Jersey, Sep 28, 2004.
- Patient-Level Data Analyses for different departments of the pharmaceutical company, Panel Moderator with IMS, SDI, and PharMetrics as panelists, SRI's 3rd Annual Pharmaceutical Marketing and Sales Summit, Buena Vista, FL, Feb 13-16, 2005.
- Molecular Targeting The New Targeting Paradigm, IIR USA's Leveraging Longitudinal Data for Segmentation, Targeting, and Strategy Formation, West Princeton at Forrestal Village, Princeton, NJ, April 11-12, 2005.
- "Leveraging Referral Patterns and Spheres of Influence through Molecular Targeting", co-presentation with Kumar Kantheti, Solvay, PMSA 2005, Gaylord Opryland Hotel, Nashville, TN, May 15-18, 2005.
- "Reconstructing the Microcosm of the Physician for Superior Targeting", co-presentation with Sanofi-Aventis, CBI 3rd Annual APLD Conference, Philadelphia, June 2-3, 2005.
| ABOUT BAYSER | | | CONTACT | | | SITE MAP |
| ©2008 Bayser Consulting. All Rights Reserved. | Site Designed by Richterworks |